Name
Session 12: Novel Targets in RCC: Advancing the Therapeutic Landscape
Date & Time
Saturday, May 3, 2025, 10:30 AM - 11:30 AM
Speakers
David Braun, Yale Cancer Center / Yale School of Medicine
Cristina Suarez Rodriguez, Vall Hebron Institute of Oncology (VHIO)
Martin Voss, MSKCC
Andrew Furness, The Royal Marsden
John Haanen, Netherlands Cancer Institute
Cristina Suarez Rodriguez, Vall Hebron Institute of Oncology (VHIO)
Martin Voss, MSKCC
Andrew Furness, The Royal Marsden
John Haanen, Netherlands Cancer Institute
Description
Chairs: Andrew Furness, MD, PhD and Martin Voss, MD
Novel Targets in RCC from the Lab's Perspective: David Braun, MD, PhD
Vaccines and Novel Cell Therapies: John Haanen, MD, PhD
Novel Targets in RCC: Lessons from Melanoma Applied in RCC: Andrew Furness, MD, PhD
Non-Immunotherapy Novel Targets: Cristina Suárez, MD, PhD
Moderated Q&A: Andrew Furness, MD, PhD and Martin Voss, MD
Location Name
Grote Zaal
Full Address
Beurs van Berlage
Damrak 243
Amsterdam-Centrum
Amsterdam NH 1012 ZJ
Netherlands
Damrak 243
Amsterdam-Centrum
Amsterdam NH 1012 ZJ
Netherlands